From interpreting conflicting laboratory results to modelling underrepresented populations, virtual hearts could help researchers assess cardiac safety earlier in drug development.
AI models learn from the data researchers collect. Expanding that evidence to include human tissues and failed experiments could improve predictions of drug efficacy and toxicity.
VivoSim's NAMkind platform puts drug candidates into contact with diseased human donor tissue, asking whether they work in MASH and IBD before anyone enrolls
Learn how developmental and reproductive toxicology study selection supports regulatory decision-making and generates meaningful nonclinical safety data.
As drug discovery adopts more human-relevant models and complex biologics, it’s increasingly important that reagents are more consistent, better characterized, and fit for purpose.
From molecular developability to functional activity, integrated characterization strategies help inform lead selection and optimization in biologics discovery.
From molecular developability to functional activity, integrated characterization strategies help inform lead selection and optimization in biologics discovery.